出 处:《中国医药》2016年第12期1819-1822,共4页China Medicine
基 金:山西省自然科学基金(2013011046-4);山西省人民医院(青年)科研项目(2010-049)
摘 要:目的 比较120 W 2 μm激光前列腺汽化剜除术与经尿道双极等离子前列腺切除术(PKRP)治疗大体积良性前列腺增生(BPH)的效果。方法 选取2011年1月至2015年1月于山西省人民医院行大体积BPH手术的患者340例,完全随机分为2组,2 μm激光组182例,行经尿道120 W 2 μm激光前列腺汽化剜除术;PKRP组158例,行PKRP。记录并比较2组手术时间、血红蛋白水平、膀胱冲洗时间、留置尿管时间、术后住院时间和手术并发症。比较2组患者手术前后国际前列腺症状评分、生活质量评分、残余尿量和最大尿流率。结果 2组均顺利完成手术,手术时间差异无统计学意义(P〉0.05)。2 μm激光组术后1 h血红蛋白水平高于PKRP组[(126.2±2.8)g/L比(106.3±5.4)g/L],膀胱冲洗时间、平均留置尿管时间和术后住院时间短于PKRP组[(8.3±2.2)h比(24.3±7.6)h、(1.9±0.7)d比(3.6±2.7)d、(2.8±1.1)d比(4.1±2.1)d],差异均有统计学意义(均P〈0.05)。2组患者术后6个月最大尿流率、残余尿量、国际前列腺症状评分和生活质量评分与术前比较均明显改善[2 μm激光组:(17.8±6.3)ml/s比(6.3±2.0)ml/s、(27±12)ml比(152±68)ml、(5.9±2.1)分比(18.1±5.8)分、(1.8±0.9)分比(4.5±1.4)分;PKRP组:(18.1±6.5)ml/s比(6.5±1.7)ml/s、(26±12)ml比(142±73)ml、(6.1±2.4)分比(18.6±6.3)分、(1.7±1.1)分比(4.4±1.8)分],差异均有统计学意义(均P〈0.05),但2组间比较差异无统计学意义(P〉0.05)。2 μm激光组轻微血尿、一过性尿路刺激症状、尿道狭窄发生率均低于PKRP组[31.9%(58/182)比100.0%(158/158)、7.7%(14/182)比15.2%(24/158)、2.2%(4/182)比4.4%(7/158)],差异均有统计学意义(均P〈0.05)。结论 120 W 2 μm激光前列腺汽化剜除术治疗大体积BPH安全有效,疗效与PKRP相似,且具有出Objective To compare the efficacy and safety of 120 W 2 μm laser vapoenucleation and transurethral plasmakinetic resection of prostate(PKRP) in the treatment of large-volume benign prostatic hyperplasia(BPH). Methods Totally 340 patients with large-volume BPH from January 2011 to January 2015 in Shanxi Provincial People′s Hospital randomly had 2 μm laser vapoenucleation(n=182, vapoenucleation group) and PKRP(n=158, PKRP group). Operation time, hemoglobin level, bladder irrigating time, catheterization time, postoperative hospital stay time and complications were recorded. International prostate symptom score(IPSS), quality of Life(QOL), post-voiding residual urine(PVR) and urinary peak flow rate(Qmax) were analyzed. Results All patients were successfully operated. The hemoglobin level at 1 h after operation in vapoenucleation group was significantly higher and bladder irrigating time, catheterization time, postoperative hospital stay time were significantly lower than those in PKRP group[(126.2±2.8)g/L vs (106.3±5.4)g/L,(8.3±2.2)h vs (24.3±7.6)h,(1.9±0.7)d vs (3.6±2.7)d,(2.8±1.1)d vs (4.1±2.1)d](P〈0.05). Qmax, PVR, IPSS and QOL at 6 months after operation were significantly improved compared to those before operation in both groups[vapoenucleation group:(17.8±6.3)ml/s vs (6.3±2.0)ml/s,(27±12)ml vs (152±68)ml,(5.9±2.1)scores vs (18.1±5.8)scores,(1.8±0.9)scores vs (4.5±1.4)scores; PKRP group:(18.1±6.5)ml/s vs (6.5±1.7)ml/s,(26±12)ml vs (142±73)ml,(6.1±2.4)scores vs (18.6±6.3)scores,(1.7±1.1)scores vs (4.4±1.8)scores](P〈0.05); there were no significantly differences between groups(P〉0.05). Incidences of mild hematuria, transient urinary tract irritation, urethral stricture in vapoenucleation group were significantly lower than those in PKRP group[31.9%(58/182) vs 100.0%(158/158), 7.7%(14/182) vs 15.2%(24/158), 2.2%(4/182
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...